Pindolol NDC 57664-655

NDC codes

FDA NDC Directory

Product NDC (as listed)57664-655Labeler and product segments. Claims need a package NDC.

Product NDC at billing width57664-0655Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
57664-655-88	57664065588	100 TABLET in 1 BOTTLE, PLASTIC (57664-655-88)Marketed from Jan 27, 1994

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pindolol
Generic name (nonproprietary): pindolol
Active ingredients: Pindolol — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Sun Pharmaceutical Industries, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 074063
Marketing start: Jan 27, 1994
Marketing end: Jan 31, 2027
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 57664-655_4d3c89dd-e947-5f23-e063-6294a90aeb1fSPL ID 4d3c89dd-e947-5f23-e063-6294a90aeb1fSPL set ID b331a73f-bf7b-4442-8901-36d016530279RxCUI 198104, 198105UNII BJ4HF6IU1DUPC 0357664655887, 0357664656884
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N457664065588 followed by a unit qualifier and the quantity

Package 57664-0655-88. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 17, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Pindolol tablets are indicated in the management of hypertension. It may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 074063

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 074063
Product	Strength	Form · route	Labeler	Product NDC
Pindolol	Pindolol 10 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-293
Pindolol	Pindolol 5 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-294
Pindolol	Pindolol 10 mg/1	TabletOral	Sun Pharmaceutical Industries, Inc.	57664-656